APOA1 and metabolic dysfunction-associated steatotic liver disease: Moreover, it was demonstrated that C57BL/6 ApoA-I−/− mice developed NAFLD, suggesting that ApoA-I can be an important modulator of processes associated with deposition of lipids in the liver and development of diet-induced NAFLD.